Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SwissGenVar: A platform for clinical grade interpretation of genetic variants to foster personalized health care in Switzerland

Dennis Kraemer, Dillenn Terumalai, Maria Livia Famiglietti, Isabel Filges, Pascal Joset, Samuel Koller, Fabienne Maurer, Stéphanie Meier, Thierry Nouspikel, Javier Sanz, Christiane Zweier, Marc Abramowicz, Wolfgang Berger, Sven Cichon, André Schaller, Andrea Superti-Furga, Valérie Barbié, View ORCID ProfileAnita Rauch
doi: https://doi.org/10.1101/2023.01.11.22283790
Dennis Kraemer
1Institute of Medical Genetics (IMG), University of Zurich (UZH), CH-8952 Schlieren/Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dillenn Terumalai
2Swiss Institute of Bioinformatics (SIB), Clinical Bioinformatics, Campus Biotech, CH-1202 Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Livia Famiglietti
3Swiss Institute of Bioinformatics (SIB), Swiss-Prot group, Centre Medicale Universitaire (CMU), CH-1211 Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Filges
4Medical Genetics, Institute of Medical Genetics and Pathology, University Hospital Basel and University of Basel, CH-4031 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascal Joset
4Medical Genetics, Institute of Medical Genetics and Pathology, University Hospital Basel and University of Basel, CH-4031 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel Koller
5Institute of Medical Molecular Genetics (IMMG), University of Zurich (UZH), CH-8952 Schlieren/Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabienne Maurer
6Division of Genetic Medicine, Lausanne University Hospital (CHUV), CH-1011 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stéphanie Meier
4Medical Genetics, Institute of Medical Genetics and Pathology, University Hospital Basel and University of Basel, CH-4031 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Nouspikel
7Genetic Medicine Division, Diagnostics Dept./Center for Genomic Medicine, Geneva University Hospitals (HUG), Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Sanz
8Department of Human Genetics, Inselspital, Bern University Hospital, CH-3010 Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christiane Zweier
8Department of Human Genetics, Inselspital, Bern University Hospital, CH-3010 Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Abramowicz
7Genetic Medicine Division, Diagnostics Dept./Center for Genomic Medicine, Geneva University Hospitals (HUG), Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Berger
5Institute of Medical Molecular Genetics (IMMG), University of Zurich (UZH), CH-8952 Schlieren/Zurich, Switzerland
9Neuroscience Center Zurich (ZNZ), University and ETH Zurich, Zurich, Switzerland
10Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Cichon
4Medical Genetics, Institute of Medical Genetics and Pathology, University Hospital Basel and University of Basel, CH-4031 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Schaller
8Department of Human Genetics, Inselspital, Bern University Hospital, CH-3010 Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Superti-Furga
6Division of Genetic Medicine, Lausanne University Hospital (CHUV), CH-1011 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valérie Barbié
2Swiss Institute of Bioinformatics (SIB), Clinical Bioinformatics, Campus Biotech, CH-1202 Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anita Rauch
1Institute of Medical Genetics (IMG), University of Zurich (UZH), CH-8952 Schlieren/Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anita Rauch
  • For correspondence: anita.rauch{at}medgen.uzh.ch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Large-scale next-generation sequencing (NGS) germline testing is technically feasible today, but variant interpretation represents a major bottleneck in analysis workflows including the extensive variant prioritization, annotation, and time-consuming evidence curation. The scale of the interpretation problem is massive, and variants of uncertain significance (VUS) are a challenge to personalized medicine. This challenge is further compounded by the complexity and heterogeneity of standards used to describe genetic variants and associated phenotypes when searching for relevant information to inform clinical decision-making.

For this purpose, all five Swiss academic Medical Genetics Institutions joined forces with the Swiss Institute of Bioinformatics (SIB) to create SwissGenVar as a user-friendly nationwide repository and sharing platform for genetic variant data generated during routine diagnostic procedures and research sequencing projects. Its objective is to provide a protected environment for expert evidence sharing about individual variants to harmonize and up-scale their significance interpretation at clinical grade following international standards. To corroborate the clinical assessment, the variant-related data are combined with consented high-quality clinical information. Broader visibility will be gained by interfacing with international databases, thus supporting global initiatives in personalized health care.

1. Introduction

Assessment of individual genetic risk factors and classification of molecular disease based on genetic contributions are hallmarks of personalized medicine [1-5]. Next to common genetic variants predisposing to, or modulating common diseases, newer evidence also indicates a significant role of individually rare variants in frequently mutated genes with strong functional consequences [6, 7]. Large-scale germline genetic testing is technically feasible today but is hampered by the difficulties in interpreting the clinical significance of variants, lack of knowledge about genotype-phenotype correlation, and long-term clinical history [8, 9]. Accurate pathogenicity interpretation of genetic variants is not only crucial for appropriate medical decision-making based on genetic evidence [10] but also for the correct stratification of research findings by genetic results [11]. A variety of international database initiatives aim to facilitate genetic variant assessment; however, these often are restricted to specific genes and/or (types of) genetic diseases/alterations and contain insufficient or contradictory, sometimes even incorrect public entries [12, 13], which mostly fail to provide accompanying valid clinical data for variant interpretation in their respective phenotypic contexts [14, 15]. Moreover, since genetic variation commonly differs among ethnicities, international data collection may not be representative and comprehensive for specific populations. The importance of local and national genetics has been exemplified by the Genome of the Netherlands initiative [16]. Therefore, the next big challenge in personalized medicine will be the expansion of high-quality genotype-phenotype databases providing “knowledge” over “data” to enable, without dictating, accurate clinical care due to rigid quality management and a sustainable expert variant curation and classification process [17, 18].

In Switzerland, research including human genetic data, as well as diagnostic germline genetic testing is strictly regulated and subject to regular quality control and accreditation procedures. Accordingly, research involving germline genetic data and diagnostic genetic testing is mainly pursued by highly specialized centers including the university and cooperating clinical centers for Medical/Human Genetics. The use of next-generation sequencing (NGS) technologies as the standard of care creates a rich source of genetic data with an in-depth clinical variant assessment that currently is not collected systematically. In Switzerland so far, there exists no nationwide academic/public database for genetic variants obtained from diagnostic procedures or sequencing research projects. Therefore, the considerable potential to promote sharing diagnostic-grade genomic data with patient-related consented high-quality clinical information remains largely untapped. Besides data protection issues, this may be explained, particularly for Swiss institutions, by the previous lack of agreed harmonized standards and concepts for genetic data collection and exchange as well as the absence of a suitable and secure repository infrastructure for genomic and related patient data.

To address these difficulties and leverage the high-quality genetic and accompanying clinical data generated in Swiss academic institutions, all five Swiss university centers for Medical/Human Genetics joined forces with the Swiss Institute of Bioinformatics (SIB, Clinical Bioinformatics) in a nationwide effort to create the SwissGenVar platform within the framework of a Swiss Personalized Health Network (SPHN) [19] infrastructure development project (project page available at [20]). SwissGenVar aims at providing a protected nationwide repository for germline variants identified in patients by Swiss clinical genetic laboratories with accompanying high-quality clinical data and an efficient joint platform for harmonization and up-scaling of expert-curated variant interpretation. However, SwissGenVar not only fosters harmonization and inclusion of diagnostic data, but also of data generated within research projects using genomic sequencing approaches. To this end, SwissGenVar ensures interoperability with international databases and the methodological and technical prerequisites for national and international sharing/storage of genomic data and evidence for standardized variant pathogenicity assessment, to facilitate consensus variant classification by clinical genetic experts. Furthermore, SwissGenVar allows the harvesting of patient-consented clinical data generated during routine health care to assess the clinical significance of a variant for a specific disease in synopsis with associated phenotypic features.

Within this project, we, therefore, defined an interoperable set of genetic and non-identifying clinical data for variant data sharing/storage and clinical interpretation, a consistent genetic variant file upload and annotation process as well as a data ontology appropriate for the creation of a protected nationwide germline variant database with accompanying high-quality clinical data and significance interpretation. The accessibility for clinicians and researchers has been realized through an efficient, scalable, and user-friendly IT infrastructure, integrated within the secure BioMedIT [21] landscape of SPHN. Currently, SwissGenVar is accessible to the project partners only, but with a scope for expansion to further academic and non-academic institutions to establish itself as the Swiss one-stop platform for the interpretation/understanding of genetic germline variants. Thus, SwissGenVar may substantially foster personalized health care, and, on the other hand, be a necessary first step to scale-up clinical-grade genetic testing and data sharing in Switzerland.

2. Materials and Methods

2.1 Sensitive data hosting and transfers

The SwissGenVar infrastructure development project has been initially funded by the Swiss Personalized Health Network (SPHN) [19] initiative which builds on the Swiss national BioMedIT infrastructure, specifically implemented for hosting sensitive data. It, therefore, uses all tools provided by those initiatives and follows their requirements.

The SwissGenVar application and data are hosted on the secure SENSA (Secure Sensitive Data Processing Platform) BioMedIT [21] node in Lausanne and comply with the SPHN and BioMedIT tools and the related Information Security Policy [22]. Data transfers are ensured by the SPHN SETT (Secure Encryption and Transfer Tool) data transfer tool [23], which encrypts, securely transfers, and decrypts data.

Users’ identity and access are managed using the BioMedIT central Keycloak [24] instance, which requires SWITCH eduID [25] two-factor authentication to log in. Keycloak is an open-access IAM platform that secures web applications and RESTful web services using standard protocols such as OAuth2, OpenID Link, and SAML 2.0. In addition, access to the system is restricted to the whitelisted IP (Internet Protocol) address ranges of each participating institution.

All data used for the development of the platform and depicted in the figures are for fictitious individuals, not real patients.

2.2 Software development

SwissGenVar is a web-based application, which backend is written in PHP (using the Laravel framework) and relies on a PostgreSQL database. The frontend is based on Vue.js (using the Nuxt framework). The bioinformatics pipeline is running on a SLURM cluster.

2.3 Public data sources

For all variants in the VCF (Variant Call Format) files, some public information is automatically gathered by the SwissGenVar platform using a local instance of the Ensembl Variant Effect Predictor (VEP) [26] deployed on the SENSA BioMedIT node. This information currently includes the variant type and effect, the genomic position of the variant, and the HGVS (Human Genome Variation Society) variant nomenclature [27].

3. Results

3.1 SwissGenVar governance and layers of access

For implementation and administration of SwissGenVar, a multicenter consortium among all five academic centers for Medical Genetics in Switzerland and the Swiss Institute of Bioinformatics (SIB) (Figure 1) has been formed, which is governed by the Steering Board, as defined in the SwissGenVar Consortium Agreement. To combine the use for research and the highest level of data protection, the platform is composed of two different modules with different potential layers of access, which are specified by the Data Transfer and Use Agreement (DTUA). The access-controlled instance is intended to share genetic data and non-identifying associated clinical/demographic metadata in view-only mode, including data submitted by any other registered group. Registered users belonging to a registered group may in addition modify their own data or metadata. The access to the data stored in the access-controlled instance is restricted to registered users of the consortium (full access layer). However, upon approval by the Steering Board, data from the access-controlled instance (including personal data) may be made accessible to users belonging to a third-party group if required for a specific research study and if authorized by the competent ethics committee (restricted access layer). By contrast, the public instance aims to make stand-alone variants and aggregated patient/proband data (without any information related to the specific patient/proband or sample) publicly available and will be freely accessible by all interested parties without registration (public access layer).

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

Involved institutions of the SwissGenVar consortium: University Hospital Basel, Medical Genetics; Department of Human Genetics, Inselspital, Bern University Hospital; Medical Genetics Service/Center for Genetic Medicine, Geneva University Hospital (HUG); Medical Genetics Service/Division of Genetic Medicine, Lausanne University Hospital (CHUV); Institute of Medical Genetics (IMG), University of Zurich (UZH); Institute of Medical Molecular Genetics (IMMG), University of Zurich (UZH); Swiss Institute of Bioinformatics (SIB); Swiss Personalized Health Network (SPHN).

3.2 Standardized SwissGenVar dataset specifications

One of the key concepts of SwissGenVar is the combination of diagnostic-grade genetic variant-related data and accompanying consented high-quality basic clinical information to corroborate their diagnostic utility. To harmonize the variant-related and phenotypic ontologies, a cross-expert working group defined a minimal and an extended genetic and clinical data set pertinent for data sharing/storage and the standardized interpretation of the clinical significance of genetic variants, which have been approved by the SwissGenVar board. After several rounds of thorough discussions and board meetings, dedicated clinical and laboratory working groups, which were managed by clinical experts for the addressed issue, elaborated a comprehensive and granular portfolio of parameters and functionalities needed for the objectives of SwissGenVar.

To ensure interoperability with international databases and other SPHN projects, SwissGenVar follows established international standards and the SPHN guidelines for Interoperability Data Standard and Tool Collection [22], whenever applicable. For most items, well-defined existing ontologies are used (Tab. 1). However, for the data fields relevant to the SwissGenVar project where no appropriate data standard was available, the consortium had to define and adapt an internal data catalogue reflecting the consensus between the practices at the different partner institutions.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Standardized core dataset. (A) Established data catalogues and data sources used in SwissGenVar.

View this table:
  • View inline
  • View popup
Table 1.

Standardized core dataset. (B) Internal data catalogues defined for SwissGenVar.

Furthermore, SwissGenVar enables automated variant annotation from a variety of sources and implements direct links to the well-established NCBI ClinVar [28] and Single Nucleotide Polymorphism Database (dbSNP) [29] as well as to Human Gene Mutation Database (HGMD) [30], DECIPHER [31], LOVD (Leiden Open Variation Database) [32] and SVIP-O [33], the latter being a Swiss SPHN platform for the clinical interpretation of genetic variants in oncology (Swiss Variant Interpretation Platform for Oncology). Additionally, the widely-used predictive algorithms SIFT (Sorting Intolerant From Tolerant) [34] and PolyPhen-2 [35] for in silico assessment of amino acid substitutions are implemented using VEP.

3.3 Data management and application workflow

The project partners provide high-quality genetic data mostly from NGS procedures (exome and genome sequencing or other methods in the form of VCF files [Variant Call Format]) either derived from research studies or diagnostic testing with general or dedicated SwissGenVar consent, which are complemented by a minimal set of basic clinical information from the relevant medical history of the patient (Figure 2). These genetic and clinical data are generated either directly by the involved laboratories or by the hospital Clinical Data Warehouses (CDW), depending on each partner institution’s setup. In both cases, genetic data are encrypted and securely transferred using the SPHN BioMedIT transfer tool [23] and are stored and accessed according to BioMedIT access and security standards [24, 25]. Subsequently, after decryption and parsing of the transferred files, patient entries are created and variant calls from the VCF files are loaded into the platform. Before being loaded, the genetic data are going through a technical basic check-up to ensure compliance with the requested VCF file format. The user can then select individual variants as “of interest” so that they are displayed in priority on the interface.

Figure 2:
  • Download figure
  • Open in new tab
Figure 2:

Synopsis of the clinical (orange) and laboratory (grey) working groups. These elaborated minimal and extended data sets of genetic and clinical data as well as functionalities pertinent to the collection, sharing, and interpretation of genetic variants. At the operational level, a regularly meeting cross-expert team was installed for content implementation.

Additionally, using a local instance of the Ensembl Variant Effect Predictor (VEP), SwissGenVar automatically retrieves publicly available annotations for each variant like gnomAD (Genome Aggregation Database) population frequency, variant effect, and the presence of the variant in public databases such as NCBI ClinVar. The implementation of additional public annotations by the integration of APIs from further data sources is being investigated. For the patients’ phenotypic features, SwissGenVar allows clinical experts to manually enter clinical information and specific findings relevant to the variant assessment on their patients via its web interface using standardized vocabularies agreed upon during the project. Only the data providers are allowed to modify their own data in case corrections or clinical data are added.

3.4 SwissGenVar database structure, data query, and data display

We developed a graphical user interface to visualize and query the data, enabling the users to explore genetic variants in a gene and/or patient of interest or to retrieve patients with specific phenotypic features. Queries can be issued either from a variant or a patient query page (Figure 3). This interface allows the creation of a custom query based on the user’s interest, with one or multiple criteria filters to search the database and display all the variants or patients matching the selected filtering criteria. The query result is displayed in a variant or patient results table, respectively, that show only selected comparable/searchable information items. However, once a specific variant or patient is selected by clicking on the corresponding row of a results table, the user can access the individual detailed page providing more granular information about the variant or the patient of interest. Thus, the detailed variant page comprises a table of all the patients harboring this specific variant along with selected related information as well as shows automatically retrieved variant annotations as detailed in Tab. 1. The detailed patient page contains a table of variants detected in the patient of interest (obtained from the VCF files) and provides diverse phenotypic features. When no filter is used, the variant and patient tables list all the variants of interest by default and patients present in the database. The pages “Uploaded patients” and “Transferred VCF files”, which are accessible via the “My Data” selection panel or menu at the top of the interface, support the users in the management of their own data and provide an overview of their submitted patients and transferred VCF files including their (validation) status. Under the detailed page of the individual patients, the clinical partner of the submitting institution can complement the patient entry with a standardized data set of non-identifying clinical and demographical information and add the granular history of medical contacts with the clinical/phenotypic findings obtained and potential genetic diagnoses. Additionally, the data provider can prioritize clinically (potentially) significant variants by flagging them as of interest (by clicking on the star symbol on the left in the variant table), which is likewise possible directly on the detailed page of the respective transferred VCF file. Finally, the application provides the option of adding variants and patients to a user’s favorite list under the individual detailed page. A notification system will be established to inform the users about any changes or updates concerning their variants or patients of interest.

Figure 3.
  • Download figure
  • Open in new tab
Figure 3.

SwissGenVar application workflow. The SwissGenVar partners provide the genetic variant data to the SwissGenVar database in VCF format. The data are encrypted and securely transferred (step 1) using the SPHN Secure Encryption and Transfer Tool (SETT). Upon transfer to the SwissGenVar private/main application server, the files are decrypted and parsed to create patient entries and load the genetic variants into the platform. The variant entries are automatically enriched with selected external public annotations (step 2). At this stage, the partners can connect to their protected account using two-factor authentication to check the transfer of their data files and start adding clinical information on their patients directly on the SwissGenVar interface (step 3). They can also query the full database to go to specific patient pages and select variants of interest using multiple pre-defined filters (step 4). In a future step, SwissGenVar will also integrate a publicly accessible platform of aggregated variant-related and clinical information for personalized medicine research.

Figure 4.
  • Download figure
  • Open in new tab
Figure 4.
  • Download figure
  • Open in new tab
Figure 4.
  • Download figure
  • Open in new tab
Figure 4.
  • Download figure
  • Open in new tab
Figure 4.

SwissGenVar variant (A) and patient (B) query pages. These pages consist of the filters bar (1); table of all/matching variants/patients with selected annotations (2); search panel to switch between variant and patient query page (3); selection panel “My data” (4) to view and edit the patients submitted by the user (under “Uploaded patients” overview and the detailed page (C)), respectively) to view the personal lists of the variants/patients of interest, or to view and edit the VCF files transferred by the user (under “Transferred VCF files” overview and the detailed page (D), respectively); menu bar (5) with a personal account and link to VCF upload service. By clicking on a row of the respective table, the users will be redirected to the individual detailed page providing further information, and in the case of the “My patients” and “Transferred VCF files” pages, to edit their own patients and VCF files. Of note, all presented data are for fictious individuals, not real patients.

4. Discussion

SwissGenVar aims to use datasets with general consent or with dedicated SwissGenVar consent to evaluate the landscape of (clinically relevant) genetic variants in Switzerland to improve variant interpretation and risk assessment by studying genotype-phenotype relation and the natural history of genetic predispositions and disorders. This shall increase our knowledge and result in respective standard operating procedures and structures for improved patient care. Therefore, SwissGenVar intends to be a nationwide repository for genetic findings in available and consented genetic data sets across all five academic Medical Genetic institutions in Switzerland and to jointly assess their clinical significance to implement standard operating procedures and improved genetic diagnostics and patient care. As main achievement, SwissGenVar allows for the collection and sharing of genetic and associated clinical data via a secure data transfer and access/query by the project partners. At the same time, it provides a platform for knowledge sharing about variant-related evidence to harmonize and upscale their significance interpretation at clinical grade with interoperability with international efforts.

For this purpose, SwissGenVar supports granular multifactorial filtering for variants and patients in separate query interfaces and details “in-house” variant-related and clinical evidence such as data from local mutation and clinical databases, and segregation as well as experimental analyses. Additionally, SwissGenVar enables its users to submit published information like published literature reports and functional studies as well as includes publicly retrievable variant annotations and links to well-established variant databases following international standards. Compared to existing genotype-phenotype/variant databases, the integration of the complete set of variant calls from the transferred VCF files and of the granular history of medical contacts and portfolio of phenotypic findings can be regarded as a big advantage in addition to the collection of genetic variants found in Swiss subpopulations [45, 46]. This allows for the comprehensive clinical assessment of variants in the synopsis of co-occurring candidate variants and the respective clinical features of the variant-carrying individual, which is supported by the option to flag several variants as of interest in the corresponding VCF files. To prompt expert discussions about significance interpretation, a notification system will inform users about any changes or updates concerning the classification of individual variants or patients of interest. Finally, the SwissGenVar project has strongly contributed to harmonizing diagnostic practices among the participating institutions by defining and standardizing ontologies for variant and related clinical data. The ontology catalogue was provided to the SPHN Data Coordination Center (DCC) [47] to serve as a basis for other (and follow-up) projects in medical genetics.

Individual findings may be followed up and, depending on the consent provided, clearly pathogenic findings with high predictive value may be fed back to the referring medical geneticist for genetic counseling of the patient. The knowledge gained for individual variants shall be annotated in the SwissGenVar database and may become publicly accessible in a public outlet of the platform integrating interfaces with international database efforts. So far, the platform is available to partner groups only, but with a scope for expansion to further academic and non-academic institutions.

5. Conclusions

In conclusion, SwissGenVar provides a protected platform for the nationwide collection of genetic germline variants and the sharing of related evidence and curated variant significance interpretations by clinical genetic experts, integrating a consistent genetic variant file upload and semi-automated annotation/curation pipeline. Thus, SwissGenVar may be regarded as a necessary first step to harmonize and scale-up clinical-grade genetic testing in Switzerland, thereby fostering personalized health research involving genetic risk stratification and disease classifications.

Data Availability

The SwissGenVar documentation and public website are available at https://pages.sib.swiss/project/swissgenvar-doc/ and https://pages.sib.swiss/project/swissgenvar/, respectively. The project GitLab site is available at URL https://gitlab.sib.swiss/clinbio/swissgenvar/sgv-knowledge/-/tree/master.

Author Contributions

Conceptualization: M.A., W.B., S.C., A.S., A.S.F., V.B. and A.R.; Methodology: D.K., D.T., L.F., I.F., P.J., S.K., F.M., S.M., T.N., J.S., C.Z., M.A., W.B., S.C., A.S., A.S.F., V.B. and A.R.; Software: D.T. and V.B.; Data Curation: D.K., D.T., L.F., I.F., P.J., S.K., F.M., S.M., T.N., J.S., C.Z., M.A., W.B., S.C., A.S., A.S.F., V.B., A.R.; Writing – Original Draft Preparation, D.K., D.T., V.B. and A.R.; Writing – Review & Editing: D.K., D.T., L.F., I.F., P.J., S.K., F.M., S.M., T.N., J.S., C.Z., M.A., W.B., S.C., A.S., A.S.F., V.B., A.R.; Visualization: D.K., D.T., V.B. and A.R.; Project Administration: A.R.; Funding Acquisition: A.R.

Funding

This platform development was funded as infrastructure development project (2018DEV13) by the Swiss Personalized Health Network (SPHN).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable. All presented data are for fictious individuals, not real patients.

Data Availability Statement

The SwissGenVar documentation and public website are available at https://pages.sib.swiss/project/swissgenvar-doc/ and https://pages.sib.swiss/project/swissgenvar/, respectively. The project GitLab site is available at URL https://gitlab.sib.swiss/clinbio/swissgenvar/sgv-knowledge/-/tree/master.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. 1.↵
    Andreu-Perez, J., Poon, C. C., Merrifield, R. D., Wong, S. T., Yang, G. Z. Big data for health. IEEE J. Biomed. Health Inform. 2015, 19, 1193–1208; DOI: 10.1109/jbhi.2015.2450362.
    OpenUrlCrossRef
  2. 2.
    Bíró, K., Dombrádi, V., Jani, A., Boruzs, K., Gray, M. Creating a common language: defining individualized, personalized and precision prevention in public health. J. Public Health (Oxf.). 2018, 40, e552–e559; DOI: 10.1093/pubmed/fdy066.
    OpenUrlCrossRef
  3. 3.
    Hasanzad, M., Sarhangi, N., Naghavi, A., Ghavimehr, E., Khatami, F., Ehsani Chimeh, S., Larijani, B., Aghaei Meybodi, H. R. Genomic medicine on the frontier of precision medicine. J. Diabetes Metab. Disord. 2022, 21, 853–861; DOI: 10.1007/s40200-021-00880-6.
    OpenUrlCrossRef
  4. 4.
    Snyderman, R. Personalized health care: from theory to practice. Biotechnol. J. 2012, 7, 973–979; DOI: 10.1002/biot.201100297.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Lek, M., Hmeljak, J., Hooper, K. M. Genetic variance in human disease - modelling the future of genomic medicine. Dis. Model Mech. 2022, 15; DOI: 10.1242/dmm.049700.
    OpenUrlCrossRef
  6. 6.↵
    Zuk, O., Hechter, E., Sunyaev, S. R., Lander, E. S. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. USA. 2012, 109, 1193–1198; DOI: 10.1073/pnas.1119675109.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Bomba, L., Walter, K., Soranzo, N. The impact of rare and low-frequency genetic variants in common disease. Genome Biol. 2017, 18, 77; DOI: 10.1186/s13059-017-1212-4.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Starita, L. M., Ahituv, N., Dunham, M. J., Kitzman, J. O., Roth, F. P., Seelig, G., Shendure, J., Fowler, D. M. Variant Interpretation: Functional Assays to the Rescue. Am. J. Hum. Genet. 2017, 101, 315–325; DOI: 10.1016/j.ajhg.2017.07.014.
    OpenUrlCrossRefPubMed
  9. 9.↵
    Hoskinson, D. C., Dubuc, A. M., Mason-Suares, H. The current state of clinical interpretation of sequence variants. Curr. Opin. Genet. Dev. 2017, 42, 33–39; DOI: 10.1016/j.gde.2017.01.001.
    OpenUrlCrossRef
  10. 10.↵
    Thouvenot, P., Ben Yamin, B., Fourrière, L., Lescure, A., Boudier, T., Del Nery, E., Chauchereau, A., Goldgar, D. E., Houdayer, C., Stoppa-Lyonnet, D., et al. Functional Assessment of Genetic Variants with Outcomes Adapted to Clinical Decision-Making. PLoS Genet. 2016, 12, e1006096; DOI: 10.1371/journal.pgen.1006096.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Sohail, M., Maier, R. M., Ganna, A., Bloemendal, A., Martin, A. R., Turchin, M. C., Chiang, C. W., Hirschhorn, J., Daly, M. J., Patterson, N., et al. Polygenic adaptation on height is overestimated due to uncorrected stratification in genome-wide association studies. Elife. 2019, 8; DOI: 10.7554/eLife.39702.
    OpenUrlCrossRefPubMed
  12. 12.↵
    Shah, N., Hou, Y. C., Yu, H. C., Sainger, R., Caskey, C. T., Venter, J. C., Telenti, A. Identification of Misclassified ClinVar Variants via Disease Population Prevalence. Am. J. Hum. Genet. 2018, 102, 609–619; DOI: 10.1016/j.ajhg.2018.02.019.
    OpenUrlCrossRefPubMed
  13. 13.↵
    Park, K. J., Lee, W., Chun, S., Min, W. K. The Frequency of Discordant Variant Classification in the Human Gene Mutation Database: A Comparison of the American College of Medical Genetics and Genomics Guidelines and ClinVar. Lab. Med. 2021, 52, 250–259; DOI: 10.1093/labmed/lmaa072.
    OpenUrlCrossRef
  14. 14.↵
    Johnston, J. J., Biesecker, L. G. Databases of genomic variation and phenotypes: existing resources and future needs. Hum. Mol. Genet. 2013, 22, R27–31; DOI: 10.1093/hmg/ddt384.
    OpenUrlCrossRefPubMed
  15. 15.↵
    Brookes, A. J., Robinson, P. N. Human genotype-phenotype databases: aims, challenges and opportunities. Nat. Rev. Genet. 2015, 16, 702–715; DOI: 10.1038/nrg3932.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat. Genet. 2014, 46, 818–825; DOI: 10.1038/ng.3021.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Bauer, P., Karges, E., Oprea, G., Rolfs, A. Unmet needs in human genomic variant interpretation. Genet. Med. 2018, 20, 376–377; DOI: 10.1038/gim.2017.187.
    OpenUrlCrossRef
  18. 18.↵
    Thorogood, A., Cook-Deegan, R., Knoppers, B. M. Public variant databases: liability? Genet. Med. 2017, 19, 838–841; DOI: 10.1038/gim.2016.189.
    OpenUrlCrossRef
  19. 19.↵
    Swiss Personalized Health Network (SPHN). Available online: https://sphn.ch/ (accessed on 09 December 2022).
  20. 20.↵
    SwissGenVar project page. Available online: https://sphn.ch/network/projects-old/infrastructure-development-projects/project-swissgenvar/ (accessed on 01 December 2022).
  21. 21.↵
    SPHN BioMedIT. Available online: https://www.biomedit.ch/ (accessed on 09 December 2022).
  22. 22.↵
    SPHN Information Security Policy Available online: https://sphn.ch/document/information-security-policy/ (accessed on 09 December 2022).
  23. 23.↵
    SPHN SETT. Available online: https://gitlab.com/biomedit/sett (accessed on 09 December 2022).
  24. 24.↵
    Keycloak Server Administration. Available online: https://www.keycloak.org/docs/latest/server_admin/ (accessed on 06 December 2022).
  25. 25.↵
    SWITCH eduID. Available online: https://www.switch.ch/edu-id/ (accessed on 06 December 2022).
  26. 26.↵
    McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R., Thormann, A., Flicek, P., Cunningham, F. The Ensembl Variant Effect Predictor. Genome Biol. 2016, 17, 122; DOI: 10.1186/s13059-016-0974-4.
    OpenUrlCrossRefPubMed
  27. 27.↵
    den Dunnen, J. T., Dalgleish, R., Maglott, D. R., Hart, R. K., Greenblatt, M. S., McGowan-Jordan, J., Roux, A. F., Smith, T., Antonarakis, S. E., Taschner, P. E. HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Hum. Mutat. 2016, 37, 564–569; DOI: 10.1002/humu.22981.
    OpenUrlCrossRefPubMed
  28. 28.↵
    Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Jang, W., et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018, 46, D1062–d1067; DOI: 10.1093/nar/gkx1153.
    OpenUrlCrossRefPubMed
  29. 29.↵
    Sherry, S. T., Ward, M., Sirotkin, K. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res. 1999, 9, 677–679; DOI.
    OpenUrlFREE Full Text
  30. 30.↵
    Stenson, P. D., Ball, E. V., Mort, M., Phillips, A. D., Shiel, J. A., Thomas, N. S., Abeysinghe, S., Krawczak, M., Cooper, D. N. Human Gene Mutation Database (HGMD): 2003 update. Hum. Mutat. 2003, 21, 577–581; DOI: 10.1002/humu.10212.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    Firth, H. V., Richards, S. M., Bevan, A. P., Clayton, S., Corpas, M., Rajan, D., Van Vooren, S., Moreau, Y., Pettett, R. M., Carter, N. P. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am. J. Hum. Genet. 2009, 84, 524–533; DOI: 10.1016/j.ajhg.2009.03.010.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    Fokkema, I. F., Taschner, P. E., Schaafsma, G. C., Celli, J., Laros, J. F., den Dunnen, J. T. LOVD v.2.0: the next generation in gene variant databases. Hum. Mutat. 2011, 32, 557–563; DOI: 10.1002/humu.21438.
    OpenUrlCrossRefPubMed
  33. 33.↵
    Caucheteur, D., Gobeill, J., Mottaz, A., Pasche, E., Michel, P. A., Mottin, L., Stekhoven, D. J., Barbié, V., Ruch, P. Text-Mining Services of the Swiss Variant Interpretation Platform for Oncology. Stud. Health Technol. Inform. 2020, 270, 884–888; DOI: 10.3233/shti200288.
    OpenUrlCrossRefPubMed
  34. 34.↵
    Ng, P. C., Henikoff, S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003, 31, 3812–3814; DOI: 10.1093/nar/gkg509.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., Sunyaev, S. R. A method and server for predicting damaging missense mutations. Nat. Methods. 2010, 7, 248–249; DOI: 10.1038/nmeth0410-248.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.
    Köhler, S., Gargano, M., Matentzoglu, N., Carmody, L. C., Lewis-Smith, D., Vasilevsky, N. A., Danis, D., Balagura, G., Baynam, G., Brower, A. M., et al. The Human Phenotype Ontology in 2021. Nucleic Acids Res. 2021, 49, D1207–d1217; DOI: 10.1093/nar/gkaa1043.
    OpenUrlCrossRefPubMed
  37. 37.
    Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015, 17, 405–424; DOI: 10.1038/gim.2015.30.
    OpenUrlCrossRefPubMed
  38. 38.
    Online Mendelian Inheritance in Man, OMIM. Available online: https://omim.org/ (accessed on 05 December 2022).
  39. 39.
    Genome Aggregation Database (gnomAD). Available online: https://gnomad.broadinstitute.org/ (accessed on 06 December 2022).
  40. 40.
    Human Genome Organisation (HUGO) Gene Nomenclature Committee at the European Bioinformatics Institute. Available online: https://www.genenames.org/ (accessed on 05 December 2022).
  41. 41.
    O’Leary, N. A., Wright, M. W., Brister, J. R., Ciufo, S., Haddad, D., McVeigh, R., Rajput, B., Robbertse, B., Smith-White, B., Ako-Adjei, D., et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016, 44, D733–745; DOI: 10.1093/nar/gkv1189.
    OpenUrlCrossRefPubMed
  42. 42.
    Cunningham, F., Allen, J. E., Allen, J., Alvarez-Jarreta, J., Amode, M. R., Armean, I. M., Austine-Orimoloye, O., Azov, A. G., Barnes, I., Bennett, R., et al. Ensembl 2022. Nucleic Acids Res. 2022, 50, D988–d995; DOI: 10.1093/nar/gkab1049.
    OpenUrlCrossRefPubMed
  43. 43.
    Church, D. M., Schneider, V. A., Graves, T., Auger, K., Cunningham, F., Bouk, N., Chen, H. C., Agarwala, R., McLaren, W. M., Ritchie, G. R., et al. Modernizing reference genome assemblies. PLoS Biol. 2011, 9, e1001091; DOI: 10.1371/journal.pbio.1001091.
    OpenUrlCrossRefPubMed
  44. 44.
    Eilbeck, K., Lewis, S. E., Mungall, C. J., Yandell, M., Stein, L., Durbin, R., Ashburner, M. The Sequence Ontology: a tool for the unification of genome annotations. Genome Biol. 2005, 6, R44; DOI: 10.1186/gb-2005-6-5-r44.
    OpenUrlCrossRefPubMed
  45. 45.↵
    Field, M. A. Bioinformatic Challenges Detecting Genetic Variation in Precision Medicine Programs. Front. Med. (Lausanne). 2022, 9, 806696; DOI: 10.3389/fmed.2022.806696.
    OpenUrlCrossRef
  46. 46.↵
    Maffucci, P., Bigio, B., Rapaport, F., Cobat, A., Borghesi, A., Lopez, M., Patin, E., Bolze, A., Shang, L., Bendavid, M., et al. Blacklisting variants common in private cohorts but not in public databases optimizes human exome analysis. Proc. Natl. Acad. Sci. USA. 2019, 116, 950–959; DOI: 10.1073/pnas.1808403116.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    SPHN Data Coordination Center (DCC). Available online: https://sphn.ch/de/projects/data-coordination-center/ (accessed on 10 December 2022).
Back to top
PreviousNext
Posted January 11, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SwissGenVar: A platform for clinical grade interpretation of genetic variants to foster personalized health care in Switzerland
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SwissGenVar: A platform for clinical grade interpretation of genetic variants to foster personalized health care in Switzerland
Dennis Kraemer, Dillenn Terumalai, Maria Livia Famiglietti, Isabel Filges, Pascal Joset, Samuel Koller, Fabienne Maurer, Stéphanie Meier, Thierry Nouspikel, Javier Sanz, Christiane Zweier, Marc Abramowicz, Wolfgang Berger, Sven Cichon, André Schaller, Andrea Superti-Furga, Valérie Barbié, Anita Rauch
medRxiv 2023.01.11.22283790; doi: https://doi.org/10.1101/2023.01.11.22283790
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SwissGenVar: A platform for clinical grade interpretation of genetic variants to foster personalized health care in Switzerland
Dennis Kraemer, Dillenn Terumalai, Maria Livia Famiglietti, Isabel Filges, Pascal Joset, Samuel Koller, Fabienne Maurer, Stéphanie Meier, Thierry Nouspikel, Javier Sanz, Christiane Zweier, Marc Abramowicz, Wolfgang Berger, Sven Cichon, André Schaller, Andrea Superti-Furga, Valérie Barbié, Anita Rauch
medRxiv 2023.01.11.22283790; doi: https://doi.org/10.1101/2023.01.11.22283790

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (755)
  • Anesthesia (221)
  • Cardiovascular Medicine (3288)
  • Dentistry and Oral Medicine (364)
  • Dermatology (277)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1169)
  • Epidemiology (13359)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5147)
  • Geriatric Medicine (481)
  • Health Economics (782)
  • Health Informatics (3264)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (429)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14622)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (127)
  • Nephrology (522)
  • Neurology (4919)
  • Nursing (262)
  • Nutrition (727)
  • Obstetrics and Gynecology (882)
  • Occupational and Environmental Health (795)
  • Oncology (2519)
  • Ophthalmology (723)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (556)
  • Psychiatry and Clinical Psychology (4205)
  • Public and Global Health (7499)
  • Radiology and Imaging (1704)
  • Rehabilitation Medicine and Physical Therapy (1011)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (205)